Role of Glutamine Metabolism during Osteoblast Differentiation and Bone Formation

谷氨酰胺代谢在成骨细胞分化和骨形成中的作用

基本信息

批准号：
9897618
负责人：
Courtney Michael Karner
金额：
$ 17.9万
依托单位：
DUKE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-04-01 至 2020-10-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9897618
关键词：
Affect Alleles American Amino Acids Anabolism Biological Bone Development Bone Regeneration Bone Resorption Bone necrosis Catabolism Cells Chronic Citric Acid Cycle Data Disease Doxycycline Enzymes Femoral Fractures Future GCLC gene Glutamate-Cysteine Ligase Glutamates Glutaminase Glutamine Glutathione Health Care Costs Human Jaw Life Maintenance Marrow Mediating Mesenchymal Stem Cells Metabolic Metabolism Molecular Mus Natural regeneration Nucleotides Obesity Osteoblasts Osteogenesis Osteoporosis Osteoporotic Oxidative Stress Pathologic Pathway interactions Patients Pharmaceutical Preparations Pharmacology Phenocopy Phosphotransferases Physiological Proteins Regulation Risk Role Signal Transduction Pathway Specific qualifier value Testing Therapeutic WNT Signaling Pathway Wild Type Mouse Work adipocyte differentiation base bone bone health bone mass cell fate specification conditionally essential amino acid defined contribution genetic approach in vivo insight mouse model new therapeutic target novel osteoblast differentiation prevent protein expression repaired skeletal stem cell differentiation stem cell fate specification stem cell population

项目摘要

Project Summary: Glutamine is a conditionally essential amino acid that has myriad uses in the cell. Aside from direct incorporation into protein, glutamine can be metabolized to generate nucleotides, other amino acids, ATP after anaplerosis into the TCA cycle, and glutathione to protect against oxidative stress. It is unknown how osteoblasts utilize glutamine and when it is required during differentiation. We recently identified glutaminase (GLS) as a critical regulator of Wnt dependent pathological bone formation. GLS deaminates glutamine to form glutamate, the first step in glutamine metabolism. Using a pharmacological approach, we demonstrated GLS activity was required for bone formation in the LRP5 human high bone mass disease mouse model. Importantly, GLS inhibition did not affect bone mass in otherwise wild type mice indicating GLS and glutamine metabolism may not be required for physiological bone formation in mice. In this proposal, we will 1) establish the necessity and sufficiency of glutaminase (GLS) to regulate osteoblast differentiation and bone formation, 2) determine if the molecular regulation of GLS activity by WNT, and 3) understand how glutamine is metabolized in mesenchymal stem cells. Our findings will have broad implications in bone development, maintenance of bone mass, skeletal repair and regeneration, as well as identify if stimulating glutamine metabolism is a viable osteoanabolic target to stimulate bone formation.

项目摘要：谷氨酰胺是有条件的必需氨基酸，在细胞中具有无数的用途。除了直接掺入蛋白质中，可以将谷氨酰胺代谢以产生核苷酸，其他氨基酸，ATP之后旋律到TCA周期，谷胱甘肽以防止氧化应激。这是未知的成骨细胞利用谷氨酰胺以及在分化过程中需要时。我们最近确定了谷氨酰胺酶（GL）是Wnt依赖病理骨形成的关键调节剂。 GL将谷氨酰胺脱氨形成谷氨酸，这是谷氨酰胺代谢的第一步。使用药理方法，我们证明了在LRP5人高骨质量疾病小鼠模型中，骨形成需要GLS活性。重要的是，GL抑制不会影响野生型小鼠的骨骼量，表明GL和谷氨酰胺小鼠生理骨形成可能不需要代谢。在此提案中，我们将建立谷氨酰胺酶（GLS）调节成骨细胞分化和骨形成的必要性和充分性，2）确定Wnt的GLS活性的分子调节，3）了解谷氨酰胺如何代谢在间充质干细胞中。我们的发现将对骨骼发育有广泛的影响，维护骨骼质量，骨骼修复和再生，并确定刺激谷氨酰胺代谢是否可行骨代谢靶标刺激骨形成。